Minnesota has become the latest state to sue Insys Therapeutics (NASDAQ:INSY), accusing the drugmaker of illegally marketing Subsys, a powerful fentanyl-based pain medication. It comes as former Insys sales representative Michelle Breitenbach pleaded guilty over bribing doctors to prescribe the drug, and as the DOJ earlier this month joined five whistleblower lawsuits accusing Insys of paying Subsys kickbacks. (big pharma chemical killer 666 NWO machines, imo!)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.